Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Janis K. Fraser, Ph.D. Photo

Background

Janis K. Fraser is a scientist-turned-lawyer who specializes in finding practical solutions to the most challenging patent issues that frequently accompany complex biotechnology and pharmaceutical inventions. A Principal in the Boston office of Fish & Richardson, Dr. Fraser has been providing strategic patent advice for over 25 years to clients ranging from startup biotech companies to multinational pharmaceutical corporations to academic institutions. She has assisted clients in obtaining patents claiming inventions such as antibodies, gene therapies, recombinant proteins, transgenic animals, pharmaceutical compounds and formulations, cosmetics, methods of treatment, and diagnostic methods. Dr. Fraser has a particular interest in patent issues surrounding personalized medicine. Her expertise extends to due diligence studies and opinions regarding validity and infringement issues.

Dr. Fraser was recognized as a “Life Science Star” by LMG Life Sciences (2012-2019), where clients are quoted as describing her as “creative, open minded, attentive to detail,” an “expert at managing difficult prosecution and opinion related issues,” and someone who possesses a “strong work ethic, and encyclopedic understanding of every facet of U.S. patent law” and is “always in possession of a creative solution.”

Education

Harvard Law School 1985
J.D.


Massachusetts Institute of Technology 1976
Biochemistry, Ph.D.


Nebraska Wesleyan University 1971
Chemistry, B.S.
with highest distinction

Admissions

  • U.S. Patent and Trademark Office 1991
  • Massachusetts 1985

Memberships & Affiliations

​Member of the Editorial Board for Life Sciences Intellectual Property Review.

Member of the Advisory Board for MIT's David H. Koch Institute for Integrative Cancer Research.

Other Distinctions

Named to “The Best Lawyers in America” list in Patent Law by The Best Lawyers in America© (2018-2020).

Named an “IP Star” by Managing Intellectual Property magazine (2014-2019).

Recognized in “IAM Patent 1000 – The World’s Leading Patent Professionals” (2016-2019).

Named a “Life Science Star” by LMG Life Sciences (2012-2019).

Named to “Best Lawyers in New England” by The Wall Street Journal (2018).

Recognized as a “World’s Leading Life Sciences Lawyer” by Who’s Who Legal (2016).

Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation” (2015-present).

Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Strategies for Patent Prosecution, Hatch-Waxman, and Litigation” (2000-2014).

Recognized as a “Top 250 Women in IP” by Managing Intellectual Property magazine (2019).

Received a “Global Award—Life Sciences Law USA” by Lawyer International (2019).

Author of articles including:

An End-Run Around Myriad And ‘Product Of Nature’ Problem,” co-author, Law360 (September 2016).

Bulletproofing Pharma Patents,” co-author, LSIPR Newsletter (December 2014).

“Patenting Genes in a Post-Myriad World,” co-author, Industrial Biotechnology (August 2013).

Myriad: Picking Up the Pieces,” LSIPR Newsletter (June 2013).

Making Follow-On Biologics a Reality,” co-author, Genetic Engineering & Biotechnology News 31:8-10 (2011).

U.S. Gene Patents in Legal Limbo—for Now,” Genetic Engineering & Biotechnology News 28:10 (2008).

Ph.D. thesis entitled “In Vitro HeLa DNA Synthesis: Investigation of the Nature of Replication and a Stimulatory Factor from HeLa Cells.”

“Patent-eligible Subject Matter in the Life Sciences in the United States,” co-author, Japanese IP Journal, Vol. 16 No. 1: 20-30 (2019).

What's trending with Janis

Filter by
News
October 2, 2019
Fish & Richardson Receives Top Firm Rankings from LMG Life Sciences in Four Practice Areas
Press Release
News
May 22, 2019
Fish & Richardson Announces 32 Attorneys Named “IP Stars” by Managing Intellectual Property Magazine
Press Release
Event
April 7th, 2019
Patent Resources Group (PRG) Spring 2019 Advanced Courses Program
Speaking Engagement
News
August 15, 2018
47 Fish Attorneys Named to The Best Lawyers in America® 2019 List
Press Release
News
June 14, 2018
Fish Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
Press Release
Event
April 15th, 2018 | 8:15 am CDT
Patent Resources Group (PRG) Spring 2018 Advanced Courses Program
Speaking Engagement
Event
April 2nd, 2017 | 8:15 am EDT
Patent Resources Group (PRG): Pharma and Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation
Speaking Engagement
Event
April 16th, 2015 | 8:00 am EDT
Patent Resources Group (PRG) Hatch-Waxman and Biosimilars: A Total Immersion Course Encompassing Strategies for Prosecution, FDA Regulation, Post-Grant Challenge, Litigation and Appeal
Speaking Engagement
Event
April 16th, 2015
Hatch-Waxman and Biosimilars: A Total Immersion Course Encompassing Strategies for Prosecution, FDA Regulation, Post-Grant Challenge, Litigation and Appeal
Speaking Engagement
Event
August 23rd, 2012
Osaka Seminars
Speaking Engagement
Event
September 29th, 2010 | 7:30 am EDT
The Biosimilars Patent Exchange
Speaking Engagement
load more topics